Glaxosmithkline (GSK)

 

GSK Share PerformanceMore

52 week high1,745.5 11/10/16
52 week low1,355.0 24/02/16
52 week change 215.5 (15.13%)
4 week volume179,140,715 24/01/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director/PDMR Shareholding

RNS Number: 2288X GlaxoSmithKline PLC 17 February 2017 GlaxoSmithKline plc (the ' Company ') Conditional Share Awards This notification sets out the vesting details of awards over Ordinary Shares and American Depositary Shares made in 2014 under the GlaxoSmithKline Performance Share Plan (PSP), which were subject to relevant business performance c...

Director/PDMR Shareholding

RNS Number: 2287X GlaxoSmithKline PLC 17 February 2017 GlaxoSmithKline plc (the ' Company ') Conditional Share Awards This notification sets out the vesting details of Deferred Bonus Awards over Ordinary Shares and American Depositary Shares made in 2014 under the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (DABP) and the associated Matchi...

Director/PDMR Shareholding

RNS Number: 2285X GlaxoSmithKline PLC 17 February 2017 GlaxoSmithKline plc (the ' Company ') Conditional Share Awards On 15 February 2017 the Company granted conditional awards to the below Executive Directors and Persons Discharging Managerial Responsibilities. The awards have been granted in accordance with the rules of the GlaxoSmithKline 2009...

Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLC

Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price...

Director/PDMR Shareholding

RNS Number: 0117X GlaxoSmithKline PLC 15 February 2017 GlaxoSmithKline plc (the ' Company ') Conditional Share Awards and Shares withheld or sold to meet tax liabilities This notification sets out the details of the vesting of awards and the sale or withholding of shares to meet tax liabilities over Ordinary Shares and American Depositary Shares made in 2014 u...

Director Deals - GlaxoSmithKline PLC (GSK)

Andrew Witty, Chief Executive Officer, has transferred out 63,441 shares in the company on the 10th February 2017 at a p...

Director/PDMR Shareholding

RNS Number: 8612W GlaxoSmithKline PLC 14 February 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Sir Andrew Witty b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market part...

Director/PDMR Shareholding

RNS Number: 8270W GlaxoSmithKline PLC 14 February 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr R G Connor b) Position/status President, Global Manufacturing & Supply c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allow...

Fundamental DataMore

P/E ratio87.207
EPS18.8
Dividend yield4.88 %

Latest discussion posts More

  • price decrease

    whats the lilkely hood of price decrease immediatly ex divi next week?
    19-Feb-2017
    onethreefive seven
  • Re: Recent Rise?

    IBT about 15% on top of the regular 1% yearly fee. Doesn't sound appealing but my family have done very well through the years just take a look at the historic growth. If you ...
    19-Feb-2017
    Johandesilva
  • Re: Recent Rise?

    What is the performance fee? I know Fundsmith questions accounting with Pharmacy, but in a world where people get old and sick I can'tell see it going out of fashion.
    18-Feb-2017
    sound money

Users' HoldingsMore

Users who hold Glaxosmithkline also hold..
VODAFONE GRP.35%
BP34%
NATIONAL GRID32%
RDS 'B'31%
LLOYDS GRP.29%

Codes & Symbols

ISINGB0009252882
SymbolsGSK, LSE:GSK, GSK.L, GSK:LN, LON:GSK, XLON:GSK